Last mentioned: Mar 15, 2026
Market Maturity
Revenue reaches $3.2B TTM as the company targets a $20B total addressable market.
Vault Expansion
The company aggressively expands its Vault platform into clinical, quality, and regulatory sectors.
Initial Public Offering
Veeva Systems goes public, establishing itself as a leader in life sciences CRM.
Veeva Systems maintains a dominant position in the life sciences cloud market, serving 15 of the top 20 biopharma firms. While revenue growth has moderated to $3.2 billion, the company's $20 billion total addressable market and high switching costs position it as a resilient long-term play.
This page surfaces every story mentioning Biopharma Industry across our healthcare coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running healthcare beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Biopharma Industry was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |